biojuice

A few IPOs happening and lined up:

Oculus Innovative Sciences [OCLS] priced today at $8 and raised about $24 million. Oculus makes “a pH-neutral, super-oxidized water that contains “oxidizing species” generated by the electrolysis of sodium chloride and water” used for wound care. [S-1] Bottled water is big business…

Rehovot-based Rosetta Genomics, is developing therapeutics and diagnostics based on MicroRNAs, and filed to raise about $32 mil. More on Rosetta at SeekingAlpha and on the F-1. Couldn’t they have come up with a more original name than Rosetta?

Also on deck: Synta, Molecular Insight, and CardioMEMS.

Pfizer Inc., the world’s largest pharmaceuticals maker, and Merck & Co. may buy biotech companies to make up for a scarcity of experimental medicines and expiring patents for best-selling products. On the shopping list are companies with experimental compounds as well as those with new drug-development science and technologies, investors at the conference said.

Bloomberg: Drugmakers’ `Arms Race’ May Spur Biotech Deals in 2007